Complementary and Alternative Care in Multiple Sclerosis
CAM Care in MS
1 other identifier
observational
1,000
1 country
1
Brief Summary
This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing the patterns of CAM use, this study will also identify and describe the positive deviants, those individuals with the highest quality of life and least amount of disease activity. Positive deviants will be compared to controls in order to describe medication, diet, and lifestyle patterns associated with a lack of MS disease progression and high quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 3, 2012
CompletedFirst Posted
Study publicly available on registry
October 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2030
February 11, 2020
February 1, 2020
18 years
October 3, 2012
February 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
"CAM Therapies" survey
This survey has been developed to identify the complementary and alternative therapies most commonly used by individuals with MS. Results will be reported with descriptive statistics.
5 years
Secondary Outcomes (1)
Modified Expanded Disability Severity Score (EDSS)
5 years
Other Outcomes (1)
PROMIS: Global Health
5 years
Study Arms (1)
Individuals with MS
Eligibility Criteria
Any individual with multiple sclerosis is invited to participate.
You may qualify if:
- Diagnosis of multiple sclerosis (including relapsing remitting MS, secondary progressive MS, primary progressive MS, clinically isolated syndromes (CIS), radiologically-isolated syndromes (RIS), possible MS, or probable MS.
- Age 18-100
You may not qualify if:
- Inability to read/write in English
- Inability or unwillingness to complete surveys every six (6) months. (\~ 90 min)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bastyr University Clinical Research Center
Kenmore, Washington, 98028, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurie K Mischley, ND, PhD, MPH
Bastyr University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Research Assistant Professor
Study Record Dates
First Submitted
October 3, 2012
First Posted
October 10, 2012
Study Start
June 1, 2012
Primary Completion (Estimated)
June 1, 2030
Study Completion (Estimated)
June 1, 2030
Last Updated
February 11, 2020
Record last verified: 2020-02